Table 1.

Summary of key outcomes for CHARM‐Added and CHARM‐Alternative.^∗Composite of first investigator reported HF hospitalisation or CV death.

	CHARM‐Added		CHARM‐Alternative
	Placebo	Candesartan	Placebo	Candesartan
Randomised	1272	1276	1015	1013
Total follow‐up (years)	3713	3848	2584	2660
All cause deaths	412	377	296	265
CV deaths	347	302	252	219
Unadjudicated composite∗	561	497	412	340
$\ge$ 1 HFH	380	323	289	211
$\ge$ 2 HFH	187	131	126	94
Number of HFHs:
1	193	192	163	117
2	91	74	58	45
3	37	24	29	21
4	21	14	16	9
5	19	8	8	10
6	6	4	7	3
7	5	3	2	2
8	3	2	3	3
9	1	0	1	0
10	1	2	2	1
11	2	0	0	0
12	1	0	0	0
Total HFH	813	589	579	422

CHARM: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity.